CDKN2A and acute lymphoblastic leukemia: Deletions in the CDKN2A/B gene have been correlated with a worse prognosis of ALL in patients of all ages, and a missense variant associated with the unique risk of ALL in European and Hispanic children has been identified, conferring a threefold increased risk for ALL [26,27].